Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
JAMA Ophthalmol. 2021 Dec 1;139(12):1285-1291. doi: 10.1001/jamaophthalmol.2021.4395.
JAMA Ophthalmol. 2021.
PMID: 34709363
Free PMC article.
Clinical Trial.
Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 Trial.
Kymes SM, Oden NL, VanVeldhuisen PC, Scott IU, Ip MS, Blodi BA, King J; SCORE2 Investigator Group.
Kymes SM, et al.
JAMA Ophthalmol. 2023 Jun 1;141(6):554-561. doi: 10.1001/jamaophthalmol.2023.1463.
JAMA Ophthalmol. 2023.
PMID: 37166820
Free PMC article.
Item in Clipboard
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.
Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Study Investigator Group.
Scott IU, et al.
JAMA Ophthalmol. 2022 May 1;140(5):458-464. doi: 10.1001/jamaophthalmol.2022.0352.
JAMA Ophthalmol. 2022.
PMID: 35323843
Free PMC article.
Clinical Trial.
Item in Clipboard
Suicidality as a Predictor of Overdose among Patients with Substance Use Disorders.
Horigian VE, Schmidt RD, Shmueli-Blumberg D, Hefner K, Feinberg J, Kondapaka R, Feaster DJ, Duan R, Gonzalez S, Davis C, Marín-Navarrete R, Tross S.
Horigian VE, et al. Among authors: kondapaka r.
J Clin Med. 2022 Oct 29;11(21):6400. doi: 10.3390/jcm11216400.
J Clin Med. 2022.
PMID: 36362628
Free PMC article.
Item in Clipboard
High suicidality predicts overdose events among people with substance use disorder: A latent class analysis.
Schmidt RD, Horigian VE, Shmueli-Blumberg D, Hefner K, Feinberg J, Kondapaka R, Feaster DJ, Duan R, Gonzalez S, Davis C, Vena A, Marín-Navarrete R, Tross S.
Schmidt RD, et al. Among authors: kondapaka r.
Front Public Health. 2023 May 16;11:1150062. doi: 10.3389/fpubh.2023.1150062. eCollection 2023.
Front Public Health. 2023.
PMID: 37261240
Free PMC article.
Item in Clipboard
Cite
Cite